Programm

40th Annual Conference and Seminar

Programme

TimeProgrammeRoom
17.00-18.00SymposiumHörsaal
17.00-18.00SymposiumBernhard von Langenbeck
18.00-19.00SymposiumHörsaal
18.00-19.00SymposiumBernhard von Langenbeck
From 19.00Get togetherFoyer

TimeProgramme
08.30-10.10Current approaches in dietary treatment
08.30-08.40From Innsbruck to Berlin
Daniela Karall (Innsbruck, AT), Sabine Scholl-Bürgi (Innsbruck, AT)
08.40-09.10From diagnosis to diet: the key role of nutrition
Marjorie Dixon (London, UK)
09.10-09.40Protein-based nutrition in ketotic GSDs: emerging concepts and changing paradigms
NN
09.40-10.10Ketogenic dietary therapy in IMD other than mitochondriopathies: from biochemistry to bedside
Sabine Scholl-Bürgi (Innsbruck, AT)
10.10-10.40Coffee & tea I Posters I Exhibition
10.40-12.10New approaches in specific inherited metabolic diseases
10.40-11.10Diet and beyond: new approaches to the treatment of classical galactosaemia
Estela Rubio Gozalbo (Maastricht, NL)
11.10-11.40Nutritional therapy in fatty acid oxidation disorders beyond childhood
Kasper W. ter Horst (Amsterdam, NL)
11.40-12.10Dietetic strategies for mitochondrial disorders: matching treatment to disease
Julia Neugebauer (Berlin)
12.10-13.30Lunch I Posters I Exhibition
13.30-14.45Aspects of experimental dietetics
13.30-13.55Microbiota-gut brain axis involvement in inherited metabolic diseases
NN
13.55-14.20The role of human milk feeding in IMD: current evidence and future directions
Alexander Höller (Innsbruck, AT)
14.20-14.45Potential risks of high-dose vitamin and trace element supplementation
Barbara Plecko (Graz, AT)
14.45-15.30Free communications I
15.30-16.00Coffee & tea I Posters I Exhibition
16.00-17.00Session of the Young Metabolic Society (JSM)
16.00-16.20Supplementtherapie bei Aminosäurendefizienzen
Nicole Hammann (Heidelberg)
17.00-18.30GfAS general assembly
From 19.30GfAS dinner
Museum für Naturkunde

TimeProgramme
08.30-10.00Free communications II
10.00-10.30Coffee & tea I Posters I Exhibition
10.30-12.15Challenges in dietary treatment
10.30-10.50Beyond clinical outcomes: understanding quality of life from the patient perspective
Maren Thiel (Berlin)
10.50-11.10Patient rights and equitable access: legal challenges in the treatment of inherited metabolic disorders
Julian März (Zurich, CH)
11.10-11.30Ethical aspects regarding indication and discontinuation of treatment
Hans-Jürgen Christen (Hanover)
11.30-12.15Discussion
Der Preis des Erfolgs: Kosten, Belastung und Umsetzung von Therapien bei angeborenen Stoffwechselstörungen
NN
12.15-12.30Farewell

Das Programm wird demnächst veröffentlicht

Das Programm wird demnächst veröffentlicht